Biobank Market Size, Trends, Analysis, and Outlook By Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems), By Service (Biobanking & Repository, Lab processing, Qualification/ Validation, Cold Chain Logistics, Others), By Biospecimen Type (Human Tissues, Organs, Stem Cells, Others), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Biobank market size is poised to register 7.82% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biobank market across By Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems), By Service (Biobanking & Repository, Lab processing, Qualification/ Validation, Cold Chain Logistics, Others), By Biospecimen Type (Human Tissues, Organs, Stem Cells, Others), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others).
The biobank market is experiencing significant growth driven by several factors in 2024 and beyond. Biobanks play a pivotal role in biomedical research by collecting, storing, and managing a diverse range of biological samples such as tissues, blood, and DNA, along with associated clinical and demographic data. Market growth is fueled by the increasing demand for high-quality biospecimens for translational research, drug discovery, and precision medicine initiatives. Moreover, the growing emphasis on personalized medicine and biomarker discovery is driving the expansion of biobank infrastructure globally, with government initiatives and funding support further propelling market growth. Additionally, advancements in biobanking technologies such as automated sample processing, cryopreservation, and data management systems are enhancing sample integrity, traceability, and accessibility, driving market adoption. Furthermore, strategic collaborations between biobanks, research institutions, and pharmaceutical companies are driving innovation, standardization, and quality assurance in biospecimen collection and utilization, shaping market trends and competitiveness.
Biobank Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biobank market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biobank survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biobank industry.
Key market trends defining the global Biobank demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biobank Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biobank industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biobank companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biobank industry
Leading Biobank companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biobank companies.
Biobank Market Study- Strategic Analysis Review
The Biobank market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Biobank industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biobank Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biobank Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biobank market segments. Similarly, Strong end-user demand is encouraging Canadian Biobank companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biobank market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biobank Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biobank industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biobank market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biobank Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biobank in Asia Pacific. In particular, China, India, and South East Asian Biobank markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biobank Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biobank Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biobank market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biobank.
Biobank Market Company Profiles
The global Biobank market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Thermo Fisher Scientific Inc., Merck KGaA, Qiagen, Hamilton Company, Tecan Trading AG, Danaher Corporation, Becton, Dickinson, and Company (BD), Biocision, LLC., Taylor-Wharton, Charles River Laboratories, Lonza, Stemcell Technologies, Biovault Family, Promocell Gmbh, Precision Cellular Storage Ltd
Recent Biobank Market Developments
The global Biobank market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biobank Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
Geographical Segmentation:
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Hamilton Company
Tecan Trading AG
Danaher Corporation
Becton, Dickinson, and Company (BD)
Biocision, LLC.
Taylor-Wharton
Charles River Laboratories
Lonza
Stemcell Technologies
Biovault Family
Promocell Gmbh
Precision Cellular Storage Ltd
Formats Available: Excel, PDF, and PPT
The biobank market is experiencing significant growth driven by several factors in 2024 and beyond. Biobanks play a pivotal role in biomedical research by collecting, storing, and managing a diverse range of biological samples such as tissues, blood, and DNA, along with associated clinical and demographic data. Market growth is fueled by the increasing demand for high-quality biospecimens for translational research, drug discovery, and precision medicine initiatives. Moreover, the growing emphasis on personalized medicine and biomarker discovery is driving the expansion of biobank infrastructure globally, with government initiatives and funding support further propelling market growth. Additionally, advancements in biobanking technologies such as automated sample processing, cryopreservation, and data management systems are enhancing sample integrity, traceability, and accessibility, driving market adoption. Furthermore, strategic collaborations between biobanks, research institutions, and pharmaceutical companies are driving innovation, standardization, and quality assurance in biospecimen collection and utilization, shaping market trends and competitiveness.
Biobank Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Biobank market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Biobank survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Biobank industry.
Key market trends defining the global Biobank demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Biobank Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Biobank industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Biobank companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Biobank industry
Leading Biobank companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Biobank companies.
Biobank Market Study- Strategic Analysis Review
The Biobank market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Biobank industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Biobank Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Biobank Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Biobank market segments. Similarly, Strong end-user demand is encouraging Canadian Biobank companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Biobank market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Biobank Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Biobank industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Biobank market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Biobank Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Biobank in Asia Pacific. In particular, China, India, and South East Asian Biobank markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Biobank Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Biobank Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Biobank market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Biobank.
Biobank Market Company Profiles
The global Biobank market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Thermo Fisher Scientific Inc., Merck KGaA, Qiagen, Hamilton Company, Tecan Trading AG, Danaher Corporation, Becton, Dickinson, and Company (BD), Biocision, LLC., Taylor-Wharton, Charles River Laboratories, Lonza, Stemcell Technologies, Biovault Family, Promocell Gmbh, Precision Cellular Storage Ltd
Recent Biobank Market Developments
The global Biobank market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Biobank Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Hamilton Company
Tecan Trading AG
Danaher Corporation
Becton, Dickinson, and Company (BD)
Biocision, LLC.
Taylor-Wharton
Charles River Laboratories
Lonza
Stemcell Technologies
Biovault Family
Promocell Gmbh
Precision Cellular Storage Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Biobank Market Overview and Key Findings, 2024
1.2 Biobank Market Size and Growth Outlook, 2021- 2030
1.3 Biobank Market Growth Opportunities to 2030
1.4 Key Biobank Market Trends and Challenges
1.4.1 Biobank Market Drivers and Trends
1.4.2 Biobank Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biobank Companies
2. BIOBANK MARKET SIZE OUTLOOK TO 2030
2.1 Biobank Market Size Outlook, USD Million, 2021- 2030
2.2 Biobank Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOBANK MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOBANK MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biobank Market, 2025
5.2 Asia Pacific Biobank Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biobank Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biobank Market, 2025
5.5 Europe Biobank Market Size Outlook by Type, 2021- 2030
5.6 Europe Biobank Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biobank Market, 2025
5.8 North America Biobank Market Size Outlook by Type, 2021- 2030
5.9 North America Biobank Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biobank Market, 2025
5.11 South America Pacific Biobank Market Size Outlook by Type, 2021- 2030
5.12 South America Biobank Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biobank Market, 2025
5.14 Middle East Africa Biobank Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biobank Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biobank Market Size Outlook and Revenue Growth Forecasts
6.2 US Biobank Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biobank Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biobank Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biobank Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biobank Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biobank Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biobank Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biobank Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biobank Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biobank Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biobank Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biobank Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biobank Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biobank Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biobank Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biobank Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biobank Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biobank Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biobank Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biobank Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biobank Industry Drivers and Opportunities
7. BIOBANK MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOBANK COMPANY PROFILES
8.1 Profiles of Leading Biobank Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Hamilton Company
Tecan Trading AG
Danaher Corporation
Becton, Dickinson, and Company (BD)
Biocision, LLC.
Taylor-Wharton
Charles River Laboratories
Lonza
Stemcell Technologies
Biovault Family
Promocell Gmbh
Precision Cellular Storage Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Biobank Market Overview and Key Findings, 2024
1.2 Biobank Market Size and Growth Outlook, 2021- 2030
1.3 Biobank Market Growth Opportunities to 2030
1.4 Key Biobank Market Trends and Challenges
1.4.1 Biobank Market Drivers and Trends
1.4.2 Biobank Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Biobank Companies
2. BIOBANK MARKET SIZE OUTLOOK TO 2030
2.1 Biobank Market Size Outlook, USD Million, 2021- 2030
2.2 Biobank Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. BIOBANK MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. BIOBANK MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Biobanking Equipment
-Temperature Control Systems
-Incubators & Centrifuges
-Alarms & Monitoring Systems
-Accessories & Other Equipment
Biobanking Consumables
Laboratory Information Management Systems
By Service
Biobanking & Repository
Lab processing
Qualification/ Validation
Cold Chain Logistics
Other Service
By Biospecimen Type
Human Tissues
Organs
Stem Cells
Others
By Type
Physical/Real Biobanks
-Tissue Biobanks
-Population Based Biobanks
-Genetic (DNA/RNA)
-Disease Based Biobanks
Virtual Biobanks
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Biobank Market, 2025
5.2 Asia Pacific Biobank Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Biobank Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Biobank Market, 2025
5.5 Europe Biobank Market Size Outlook by Type, 2021- 2030
5.6 Europe Biobank Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Biobank Market, 2025
5.8 North America Biobank Market Size Outlook by Type, 2021- 2030
5.9 North America Biobank Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Biobank Market, 2025
5.11 South America Pacific Biobank Market Size Outlook by Type, 2021- 2030
5.12 South America Biobank Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Biobank Market, 2025
5.14 Middle East Africa Biobank Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Biobank Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Biobank Market Size Outlook and Revenue Growth Forecasts
6.2 US Biobank Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Biobank Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Biobank Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Biobank Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Biobank Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Biobank Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Biobank Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Biobank Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Biobank Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Biobank Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Biobank Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Biobank Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Biobank Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Biobank Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Biobank Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Biobank Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Biobank Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Biobank Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Biobank Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Biobank Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Biobank Industry Drivers and Opportunities
7. BIOBANK MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. BIOBANK COMPANY PROFILES
8.1 Profiles of Leading Biobank Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Hamilton Company
Tecan Trading AG
Danaher Corporation
Becton, Dickinson, and Company (BD)
Biocision, LLC.
Taylor-Wharton
Charles River Laboratories
Lonza
Stemcell Technologies
Biovault Family
Promocell Gmbh
Precision Cellular Storage Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
